Chopra Rajesh,Lopez-Girona Antonia,Hege Kristen Mae
申请号：
NZ62945614
公开号：
NZ629456A
申请日:
2014.04.16
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
Disclosed herein is the use of an effective amount of an effective amount of a TOR kinase inhibitor represented by structural formula (I) and an effective amount of IMiD immunomodulatory drug in the manufacture of a medicament for treating or preventing cancer, particularly blood borne cancer which includes a lymphoma, a leukemia or a mutliple myeloma, wherein the variables shown in formula (I) are as defined in the specification.
